Evommune
IPOEvommune is a biotech company in Redwood City, United States, founded in 2020. It has raised $255.5M across 4 rounds, most recently a $115.0M Series C in October 2024.
Novel Therapies for Chronic Inflammatory Disease
- Headquarters
- Redwood City, California
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- evommune.com
- Total Funding
- $255.5M
- Last Round
- $115.0M Series COct 2024
- Rounds
- 4
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 4 funding rounds and 4 investors for this company. The full record is or through the API.
About
Clinical-stage biopharma developing novel therapies for immune-mediated chronic inflammatory diseases including atopic dermatitis.
Summary
It lists 11–50 employees. It has raised $255.5M in total across 4 rounds, most recently a $115.0M Series C round in Oct 2024. Investors include RA Capital Management, Arix Bioscience and Sectoral Asset Management.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Nov 2025
Sign up to see all 5 events
Funding: Series A through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/evommune"><img src="https://indexed.vc/api/badge/company/evommune" alt="Evommune on Indexed.vc" width="260" height="76" /></a>